Get 20% lifetime commission for referring investors to digrin.com
here.
Organogenesis Holdings Inc. ( ORGO) - Key Metrics
ORGO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.34 | -$0.77 | -$0.25 | -$0.25 |
| 2026Q1 | $0.29 | -$0.44 | $0.17 | $0.14 |
| 2025Q4 | $1.77 | $0.34 | $0.31 | $0.27 |
| 2025Q3 | $1.19 | $0.17 | $0.02 | $0.01 |
| 2025Q2 | $0.79 | -$0.07 | -$0.26 | -$0.29 |
ORGO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.79 |
| 2026Q1 | 0% | -1.35 |
| 2025Q4 | 0% | 4.62 |
| 2025Q3 | 0% | 9.59 |
| 2025Q2 | 0% | -9.51 |
ORGO
Price: $1
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.79 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 317113
Market Capitalization: 171.1 million